Illumina, Inc. ( ILMN) - Stock Earnings
ILMN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026, midnight | — / — | — | — / — | — |
ILMN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 334.0 million USD | 1.2 billion USD |
| 2026Q1 | 134.0 million USD | 1.1 billion USD |
| 2026Q2 | 207.0 million USD | 1.2 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ILMN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.2 billion USD | 4.5 billion USD |
| 2024 | -1.2 billion USD | 4.4 billion USD |
| 2025 | 850.0 million USD | 4.3 billion USD |
| 2026 Est. | — | — |
ILMN
Price: $269.40
Earnings Per Share: 5.36 USD
P/E Ratio: 37.29
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.1 million
Ebitda: 273.0 millionMarket Capitalization: 40.5 billion